1. Right ventricular involution: What can we learn from nature's model of compensated hypertrophy?
- Author
-
Megan E. Bowen, Stavros G. Drakos, Dean Y. Li, Xiaoqing Liu, Peter M. Sundwall, Stephen H. McKellar, and Craig H. Selzman
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Time Factors ,Heart Ventricles ,Ventricular Dysfunction, Right ,PAWR ,Apoptosis ,030204 cardiovascular system & hematology ,Ventricular Function, Left ,Muscle hypertrophy ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Autophagy ,Medicine ,Animals ,Involution (medicine) ,TUNEL assay ,Hypertrophy, Right Ventricular ,Ventricular Remodeling ,business.industry ,Age Factors ,Mice, Inbred C57BL ,Disease Models, Animal ,Editorial Commentary ,Fetal circulation ,medicine.anatomical_structure ,Terminal deoxynucleotidyl transferase ,Animals, Newborn ,Gene Expression Regulation ,Ventricle ,030220 oncology & carcinogenesis ,Cardiology ,Ventricular Function, Right ,Surgery ,Cardiology and Cardiovascular Medicine ,business ,Apoptosis Regulatory Proteins ,Signal Transduction - Abstract
Background Right ventricular (RV) failure (RVF) is a vexing problem facing patients with various disease processes and carries a high mortality. RVF is a poorly understood phenomenon with limited treatment options. In mammalian fetal circulation, the right ventricle is the systemic ventricle. In neonates, however, the left ventricle assumes that role and gradually thickens compared with the right ventricle. This process, known as right ventricular involution (RVI), is poorly understood. We sought to define the time course and identify mechanisms involved in RVI. Methods Wild-type mice were bred and sacrificed on day of life (DOL) 1, 4, 8, 16, and 30 to evaluate left ventricular (LV) and RV wall thickness and apoptosis. A terminal deoxynucleotidyl transferase nick-end labeling assay and RNA sequencing were performed to measure changes during RVI. Results Morphometric analysis demonstrated the changes in RV and LV wall thickness occurring between DOL 1 and DOL 16 (RV:LV, 0.53:0.44; P = .03). In addition, apoptosis was most active early, with the highest percentage of apoptotic cells on DOL 1 (1.0%) and a significant decrease by DOL 30 (0.23%) ( P = .02). Similarly, expression of the proapoptotic genes BCL2l11 and Pawr were increased at DOL 1, and the antiapoptotic genes Nol3 and Naip2 were significantly increased at DOL 30. Conclusions RVI is a misnomer, but significant changes occur early (by DOL 16) in neonatal mouse hearts. Apoptosis plays a role in RVI, but whether manipulation of apoptotic pathways can prevent or reverse RVI is unknown and warrants further investigation.
- Published
- 2017